PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations

Background: Ovarian cancer is the 7th most common cancer and 8th most mortal cancer among woman. The standard treatment includes cytoreduction surgery followed by chemotherapy. Unfortunately, in most cases, after treatment, cancer develops drug resistance. Decreased expression and/or activity of pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Świerczewska, Monika, Sterzyńska, Karolina, Wojtowicz, Karolina, Kaźmierczak, Dominika, Iżycki, Dariusz, Nowicki, Michał, Zabel, Maciej, Januchowski, Radosław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515253/
https://www.ncbi.nlm.nih.gov/pubmed/31027318
http://dx.doi.org/10.3390/ijms20082053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515253/
https://www.ncbi.nlm.nih.gov/pubmed/31027318
http://dx.doi.org/10.3390/ijms20082053

Ejemplares similares